However, TGF-β has also been reported to modulate the activation and status of the other components of the TME (including MDSCs, lymphocytes, neutrophils, dendritic cells, cancer-associated fibroblasts) (Pickup et al., 2013). The gene discussed is TGFB1; the disease is cancer.